Premium
Asymptomatic patients with severe hypertrophic obstructive cardiomyopathy: New perspectives on early percutaneous treatment
Author(s) -
Musumeci Giuseppe,
Colopi Marzia
Publication year - 2021
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.29536
Subject(s) - medicine , asymptomatic , obstructive cardiomyopathy , hypertrophic cardiomyopathy , percutaneous , cardiology , cardiomyopathy , heart failure
Key Points Hypertrophic cardiomyopathy is the most common genetic cardiac disease. Reverse cardiac remodeling after alcohol septal ablation has been reported in patients with obstructive hypertrophic cardiomyopathy who are symptomatic despite medical therapy. No data exist on early percutaneous therapy to reverse adverse remodeling and improve prognosis in asymptomatic patients with severe left ventricular outflow tract obstruction.